by Jason Heaviland | Jul 8, 2026
Untargeted Metabolomic and Lipidomic Profiling as a Supplemental Assay for Diagnosis of Periodontitis July 28, 2026 | 12:00 PM ET Traditional methods for diagnosing periodontitis rely on clinical examinations and radiographic imaging, but these approaches may not...
by Jason Heaviland | Apr 30, 2026
Advancing the frontier of translational proteomic insights: Focus on large scale mass spectrometry A fireside conversation for biopharma, investors, and academics about maximizing translational insights from proteomic data by capitalizing on the emergence of...
by Jason Heaviland | Mar 2, 2026
Chemical Exposure Profiling of Alzheimer’s Patients This webinar presents a comprehensive overview of chemical exposure profiling in Alzheimer’s patients using Panome Bio’s Targeted Exposomics™ and Discovery Exposomics™ platforms. Learn how quantitative exposure...
by Jason Heaviland | Nov 6, 2025
Inside PRMT5: Metabolomics-Driven Insights for Cancer Therapy PRMT5 is a promising therapeutic target, especially in MTAP-deleted tumors, but measuring its inhibition has remained a challenge. In this webinar, Panome Bio scientists introduce a targeted metabolite...
by ODWAdmin | Sep 23, 2025
Microbiome Function Through the Lens of Metabolomics This webinar, featuring Dr. Andrew Patterson of Penn State University, will explore how metabolomics is advancing our understanding of host–microbiome interactions, with a special focus on bile acids. Traditionally...
